An observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose IFN therapy.
An observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose IFN therapy.
Study Type
OBSERVATIONAL
Enrollment
1,230
blood drawn for a Binding Antibody (BAb) and Neutralizing Antibody (NAb) test.
Proportion of subjects whose high dose IFN therapy had changed in the regularly scheduled NAbs testing arm versus the Usual Care Arm
Time frame: 1 year
The nature of any therapy/management change in each arm
Time frame: 1 year
Reason for change in therapy/management
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Phoenix Neurological Associates, LTD
Phoenix, Arizona, United States
East Bay Physicians Medical Group
Berkley, California, United States
Neuro-Pain Medical Center
Fresno, California, United States
Fullerton Neurology and Headache Center
Fullerton, California, United States
University of Southern California
Los Angeles, California, United States
University of California, Davis
Sacramento, California, United States
Neurology Clinic of Marin
San Anselmo, California, United States
Colorado Springs Neurological Associates, PC
Colorado Springs, Colorado, United States
Colorado Neurosurgery
Engelwood, Colorado, United States
The Emery Neuroscience Center
Fort Lauderdale, Florida, United States
...and 39 more locations